These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Value of technetium-99m HMPAO-labelled leucocyte scintigraphy as an initial screening test in patients suspected of having inflammatory bowel disease. Giaffer MH; Tindale WB; Holdsworth D Eur J Gastroenterol Hepatol; 1996 Dec; 8(12):1195-200. PubMed ID: 8980940 [TBL] [Abstract][Full Text] [Related]
3. Imaging inflammation: current role of labeled autologous leukocytes. Peters AM J Nucl Med; 1992 Jan; 33(1):65-7. PubMed ID: 1730998 [No Abstract] [Full Text] [Related]
4. 99Tcm and 111In leucocyte scintigraphy in inflammatory bowel disease. Li DJ; Middleton SJ; Wraight EP Nucl Med Commun; 1992 Dec; 13(12):867-70. PubMed ID: 1465269 [TBL] [Abstract][Full Text] [Related]
5. Technetium-99m HMPAO labelled leucocyte scanning in the initial diagnosis of Crohn's disease. Bury B Br J Radiol; 1995 Apr; 68(808):437. PubMed ID: 7795986 [No Abstract] [Full Text] [Related]
6. Quantitative assessment of overall inflammatory bowel disease activity using labelled leucocytes: a direct comparison between indium-111 and technetium-99m HMPAO methods. Mansfield JC; Giaffer MH; Tindale WB; Holdsworth CD Gut; 1995 Nov; 37(5):679-83. PubMed ID: 8549945 [TBL] [Abstract][Full Text] [Related]
7. Imaging of inflammatory bowel disease (IBD) and scintigraphic assessment of resected colon: comparison of 111 In-oxine and 99mTC HMPAO leucocyte labelling. Moisan A; Lecloirec J; Bretagne JF; Loreal O; Raoul JL; Herry JY Prog Clin Biol Res; 1990; 355():159-64. PubMed ID: 2126373 [No Abstract] [Full Text] [Related]
8. Leukocyte scintigraphy to assess disease activity in inflammatory bowel disease. Papós M; Nagy F; Láng J; Csernay L J Nucl Med; 1996 Feb; 37(2):400. PubMed ID: 8667083 [No Abstract] [Full Text] [Related]
9. Is it possible to assess disease activity of inflammatory bowel disease with scintigraphy? Arndt JW; Grootscholten MI Neth J Med; 1996 Feb; 48(2):49-52. PubMed ID: 8819798 [TBL] [Abstract][Full Text] [Related]
10. Comparison of 99m technetium hexamethylpropylene-amine oxime labelled leucocyte with 111-indium tropolonate labelled granulocyte scanning and ultrasound in the diagnosis of intra-abdominal abscess. Weldon MJ; Joseph AE; French A; Saverymuttu SH; Maxwell JD Gut; 1995 Oct; 37(4):557-64. PubMed ID: 7489945 [TBL] [Abstract][Full Text] [Related]
14. [Nuclear medicine methods for diagnosis of abdominal inflammation]. Becker W; Wolf F Z Gastroenterol Verh; 1991 Mar; 26():125-30. PubMed ID: 1714122 [No Abstract] [Full Text] [Related]
15. Technetium-99m-HMPAO labelled leucocytes in the detection and monitoring of inflammatory bowel disease in children. Jewell FM; Davies A; Sandhu B; Duncan A; Grier D Br J Radiol; 1996 Jun; 69(822):508-14. PubMed ID: 8757652 [TBL] [Abstract][Full Text] [Related]
16. Abdominal scintigraphy using technetium Tc 99m hexylmethylpropylene amine oxime-labeled leukocytes in patients with seronegative spondyloarthropathies. Elkayam O; Paran D; Even-Sapir E; Litinsky I; Wigler I; Yaron M; Caspi D Semin Arthritis Rheum; 2002 Jun; 31(6):406-12. PubMed ID: 12077713 [TBL] [Abstract][Full Text] [Related]
17. Technetium-99m hexamethyl propylene amine oxine leucocytes in the assessment of disease activity in inflammatory bowel disease. Lantto E; Järvi K; Krekelä I; Lantto T; Taavitsainen M; Vedenkangas H; Vorne M Eur J Nucl Med; 1992; 19(1):14-8. PubMed ID: 1547802 [TBL] [Abstract][Full Text] [Related]
18. Abdominal scintigraphy using 99mTc-HMPAO-labelled leucocytes in patients with seronegative spondylarthropathies without clinical evidence of inflammatory bowel disease. Alonso JC; Lopez-Longo FJ; Lampreave JL; González CM; Vegazo O; Carreño L; Almoguera I Eur J Nucl Med; 1996 Mar; 23(3):243-6. PubMed ID: 8599954 [TBL] [Abstract][Full Text] [Related]